Dld Asset Management, LP Bristol Myers Squibb CO Call Options Transaction History

Dld Asset Management, LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $13.4 Million - $14.8 Million	-300,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $13.5 Million - $16.1 Million	300,000 New	300,000 $14.3 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $24 Million - $26.1 Million	-400,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $22.1 Million - $25.5 Million	400,000	400,000 $25.5 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.